Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imara Announces FDA Fast Track Designation for IMR-687 for Sickle Cell Disease

americanpharmaceuticalreviewMay 30, 2019

Tag: FDA , Imara , IMR-687

PharmaSources Customer Service